Cargando…

Acetylation in Tumor Immune Evasion Regulation

Acetylation is considered as one of the most common types of epigenetic modifications, and aberrant histone acetylation modifications are associated with the pathological process of cancer through the regulation of oncogenes and tumor suppressors. Recent studies have shown that immune system functio...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Jun, He, Xiang, Zhang, Lijuan, Zhang, Ran, Li, Wenzheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645962/
https://www.ncbi.nlm.nih.gov/pubmed/34880761
http://dx.doi.org/10.3389/fphar.2021.771588
_version_ 1784610422409658368
author Lu, Jun
He, Xiang
Zhang, Lijuan
Zhang, Ran
Li, Wenzheng
author_facet Lu, Jun
He, Xiang
Zhang, Lijuan
Zhang, Ran
Li, Wenzheng
author_sort Lu, Jun
collection PubMed
description Acetylation is considered as one of the most common types of epigenetic modifications, and aberrant histone acetylation modifications are associated with the pathological process of cancer through the regulation of oncogenes and tumor suppressors. Recent studies have shown that immune system function and tumor immunity can also be affected by acetylation modifications. A comprehensive understanding of the role of acetylation function in cancer is essential, which may help to develop new therapies to improve the prognosis of cancer patients. In this review, we mainly discussed the functions of acetylase and deacetylase in tumor, immune system and tumor immunity, and listed the information of drugs targeting these enzymes in tumor immunotherapy.
format Online
Article
Text
id pubmed-8645962
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-86459622021-12-07 Acetylation in Tumor Immune Evasion Regulation Lu, Jun He, Xiang Zhang, Lijuan Zhang, Ran Li, Wenzheng Front Pharmacol Pharmacology Acetylation is considered as one of the most common types of epigenetic modifications, and aberrant histone acetylation modifications are associated with the pathological process of cancer through the regulation of oncogenes and tumor suppressors. Recent studies have shown that immune system function and tumor immunity can also be affected by acetylation modifications. A comprehensive understanding of the role of acetylation function in cancer is essential, which may help to develop new therapies to improve the prognosis of cancer patients. In this review, we mainly discussed the functions of acetylase and deacetylase in tumor, immune system and tumor immunity, and listed the information of drugs targeting these enzymes in tumor immunotherapy. Frontiers Media S.A. 2021-11-22 /pmc/articles/PMC8645962/ /pubmed/34880761 http://dx.doi.org/10.3389/fphar.2021.771588 Text en Copyright © 2021 Lu, He, Zhang, Zhang and Li. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Lu, Jun
He, Xiang
Zhang, Lijuan
Zhang, Ran
Li, Wenzheng
Acetylation in Tumor Immune Evasion Regulation
title Acetylation in Tumor Immune Evasion Regulation
title_full Acetylation in Tumor Immune Evasion Regulation
title_fullStr Acetylation in Tumor Immune Evasion Regulation
title_full_unstemmed Acetylation in Tumor Immune Evasion Regulation
title_short Acetylation in Tumor Immune Evasion Regulation
title_sort acetylation in tumor immune evasion regulation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8645962/
https://www.ncbi.nlm.nih.gov/pubmed/34880761
http://dx.doi.org/10.3389/fphar.2021.771588
work_keys_str_mv AT lujun acetylationintumorimmuneevasionregulation
AT hexiang acetylationintumorimmuneevasionregulation
AT zhanglijuan acetylationintumorimmuneevasionregulation
AT zhangran acetylationintumorimmuneevasionregulation
AT liwenzheng acetylationintumorimmuneevasionregulation